Sur, Nicole B. MD
doi : 10.1161/STROKEAHA.123.043538
Volume 54(6) pgs. 1463-1705,e231-e293 June 2023
Chen, Ze-Jian MD ,,*; He, Chang PhD ,,*; Xu, Jiang MD; Zheng, Chan-Juan MD; Wu, Jing MD; Xia, Nan MD; Hua, Qiang MD; Xia, Wen-Guang MD; Xiong, Cai-Hua PhD; Huang, Xiao-Lin MD, PhD
doi : 10.1161/STROKEAHA.122.041480
Robot-assisted arm training is generally delivered in the robot-like manner of planar or mechanical 3-dimensional movements. It remains unclear whether integrating upper extremity (UE) natural coordinated patterns into a robotic exoskeleton can improve outcomes.
Dobkin, Bruce H. MD; Busza, Ania MD, PhD
Singh, Nishita MD; Cimflova, Petra MD; Ospel, Johanna Maria MD; Kashani, Nima MD; Marko, Martha MD; Mayank, Arnuv BSc; Nogueira, Raul G. MD; McTaggart, Ryan A. MD; Demchuk, Andrew M. MD; Poppe, Alexandre Y. MD; Rempel, Jeremy L. MD; Field, Thalia S. MD; Dowlatshahi, Dar MD; van Adel, Brian MD; Swartz, Richard H. MD; Shah, Ruchir MD; Sauvageau, Eric MD; Puetz, Volker MD; Silver, Frank L. MD; Campbell, Bruce MD; Chapot, Rene MD; Tymianski, Michael MD; Goyal, Mayank MD; Almekhlafi, Mohammed A. MD; Hill, Michael D. MD; on behalf of the ESCAPE-NA1 Trial Investigators
doi : 10.1161/STROKEAHA.122.042200
Infarct in a new territory (INT) is a known complication of endovascular stroke therapy. We assessed the incidence of INT, outcomes after INT, and the impact of concurrent treatments with intravenous thrombolysis and nerinetide.
Coexistence of intracranial atherosclerotic stenosis (ICAS) and unruptured intracranial aneurysms (UIAs) is increasingly encountered in clinical practice.
doi : 10.1161/STROKEAHA.122.041553
Coexistence of intracranial atherosclerotic stenosis (ICAS) and unruptured intracranial aneurysms (UIAs) is increasingly encountered in clinical practice.
Kuroda, Satoshi MD; Yamamoto, Shusuke MD; Funaki, Takeshi MD; Fujimura, Miki MD; Kataoka, Hiroharu MD; Hishikawa, Tomohito MD; Takahashi, Jun MD; Endo, Hidenori MD; Nariai, Tadashi MD; Osato, Toshiaki MD; Saito, Nobuhito MD; Sato, Norihiro MD; Hori, Emiko MD; Ito, Yoichi M. PhD; Miyamoto, Susumu MD; the AMORE Study Group; Inaji, Motoki; Morita, Kenichi; Maruyama, Daisuke; Nakagawara, Jyoji; Hashimura, Naoki; Hamano, Eika; Iihara, Koji; Hashimoto, Nobuo; Honjo, Kaori; Nakamura, Hirohiko; Kashiwazaki, Daina; Imai, Hideaki; Miyawaki, Satoru; Hongo, Hiroki; Yoshida, Kazumichi; Kikuchi, Takayuki; Mineharu, Yohei; Isozaki, Makoto; Kikuta, Kenichiro; Araki, Yoshio; Kanamori, Fumiaki; Date, Isao; Ono, Junichi; Machida, Toshio; Mase, Mitsuhito; Katano, Hiroyuki; Yamaguchi, Koji; Kawamata, Takakazu; Tominaga, Teiji; Uchino, Haruto; Tokairin, Kikutaro; Ito, Masaki; Houkin, Kiyohiro; Chida, Kohei; Ogasawara, Kuniaki; Nagata, Izumi; Horie, Nobutaka; Oka, Hidehiro; Kumabe, Toshihiro; Itoh, Yoshiaki; Abe, Takato; Oki, Koichi; Takahashi, Shinichi; Suzuki, Norihiro
doi : 10.1161/STROKEAHA.122.041932
Long-term outcomes are unknown in patients with asymptomatic moyamoya disease. In this report, we aimed to clarify their 5-year risk of stroke and its predictors.
Akay, Ela Marie Z. ,*; Hilbert, Adam MSc ,*; Carlisle, Benjamin G. PhD; Madai, Vince I. MD, PhD; Mutke, Matthias A. MD; Frey, Dietmar MD, JD
doi : 10.1161/STROKEAHA.122.041442
Established randomized trial-based parameters for acute ischemic stroke group patients into generic treatment groups, leading to attempts using various artificial intelligence (AI) methods to directly correlate patient characteristics to outcomes and thereby provide decision support to stroke clinicians.
Bravata, Dawn M. MD; Ranta, Anna MD, PhD
Tjokrowijoto, Priscilla BA; Stolwyk, Renerus J. PhD; Ung, David PhD; Kneebone, Ian PsychD; Kilkenny, Monique F. PhD; Kim, Joosup PhD; Olaiya, Muideen T. PhD; Dalli, Lachlan L. PhD; Cadilhac, Dominique A. PhD; Nelson, Mark R. PhD; Lannin, Natasha A. PhD; Andrew, Nadine E. PhD; on behalf of the PRECISE Investigators
doi : 10.1161/STROKEAHA.122.041355
Untreated poststroke mood problems may influence long-term outcomes. We aimed to investigate factors associated with receiving mental health treatment following stroke and impacts on long-term outcomes.
Terrill, Alexandra L. PhD
Fishman, Boris MD, MPH; Bardugo, Aya MD, MSc; Zloof, Yair MD; Bendor, Cole D. MD; Libruder, Carmit MSc; Zucker, Inbar MD, MPH, MBA; Lutski, Miri PhD; Ram, Amit RN, MPH; Hershkovitz, Yael MSc; Orr, Omri MD, MPH; Omer, Ma'ayan MD; Furer, Ariel MD, MBA; Goldman, Adam MD, MPH; Yaniv, Gal MD, PhD; Tanne, David MD; Derazne, Estela MSc; Tzur, Dorit MBA; Afek, Arnon MD, MHA; Grossman, Ehud MD; Twig, Gilad MD, MPH, PhD
doi : 10.1161/STROKEAHA.122.042100
Adult hypertension is a well-established risk factor for stroke in young adults (aged <55 years), and the effects are even more deleterious than at an older age.
Renedo, Daniela MD ,,*; Acosta, Julian N. MD ,*; Koo, Andrew B. MD; Rivier, Cyprien MD, MS; Sujijantarat, Nanthiya MD; de Havenon, Adam MD, MSCI; Sharma, Richa MD, MPH; Gill, Thomas M. MD; Sheth, Kevin N. MD; Falcone, Guido J. MD, ScD, MPH ,+; Matouk, Charles C. MD ,+
doi : 10.1161/STROKEAHA.122.041891
Frailty is a prevalent state associated with several aging-related traits and conditions. The relationship between frailty and stroke remains understudied.
Teo, Kay-Cheong MBBS, FHKAM; Fong, Sze-Man MBBS; Leung, William C.Y. MBBS; Leung, Ian Y.H. MBBS, FHKAM; Wong, Yuen-Kwun PhD; Choi, Olivia M.Y. MPsych; Yam, Ka-Keung MBBS, FHKAM; Lo, Rachel C.N. BSc; Cheung, Raymond T.F. MD, PhD; Ho, Shu-Leong MD; Tsang, Anderson C.O. MS; Leung, Gilberto K.K. MS, PhD; Chan, Koon-Ho MD, PhD ,,,*; Lau, Kui-Kai DPhil ,,,*
doi : 10.1161/STROKEAHA.122.041246
Major intracerebral hemorrhage (ICH) trials have largely been unable to demonstrate therapeutic benefit in improving functional outcomes.
Dowlatshahi, Dar MD, PhD; Jamal, Mobin MD, MSc; Raposo, Nicolas MD, PhD
Scheldeman, Lauranne MD, PhD; Wouters, Anke MD, PhD; Bertels, Jeroen PhD; Dupont, Patrick PhD; Cheng, Bastian MD; Ebinger, Martin MD; Endres, Matthias MD; Fiebach, Jochen B. MD; Gerloff, Christian MD; Muir, Keith W. MD; Nighoghossian, Norbert MD; Pedraza, Salvador MD, PhD; Simonsen, Claus Z. MD, PhD; Thijs, Vincent MD, PhD; Thomalla, Gotz MD; Lemmens, Robin MD, PhD
doi : 10.1161/STROKEAHA.122.041505
Reversibility of the diffusion-weighted imaging (DWI) lesion means that not all of the DWI lesion represents permanently injured tissue.
Miao, Jian MS ,,*; Sang, Hongfei MD ,*; Li, Fengli MD ,*; Saver, Jeffrey L. MD; Lei, Bo MD; Li, Jinglun MD; Nogueira, Raul Gomes MD; Song, Bo MS; Liu, Shudong MS; Nguyen, Thanh N. MD; Jin, Zhenglong MD; Zeng, Hongliang MS; Wen, Changming MS; Yuan, Guangxiong MS; Kong, Weilin MD; Luo, Weidong MS; Liu, Shuai MS; Xie, Dongjing MS; Huang, Jiacheng MD; Liu, Chang MD; Yang, Jie MS; Hu, Jinrong MS; Song, Jiaxing MS; Yue, Chengsong MS; Li, Linyu MS; Tian, Yan MS; Zhang, Xiao MS; Feng, Dan MS; Gao, Yani MS; Fu, Huiying MS; Zi, Wenjie MD; Yang, Qingwu MD; Qiu, Zhongming MD; Wang, Shaojun MD
doi : 10.1161/STROKEAHA.122.042203
The effect of imaging selection paradigms on endovascular thrombectomy outcomes in patients with acute ischemic stroke with large vessel occlusion remains uncertain.
Jareczek, Francis J. MD, PhD; Farrell, Mary Beth EdD; Lehman, Erik B. MS; Sila, Cathy MD; Terry, John B. MD; Sacks, David MD; Kalapos, Paul MD; Simon, Scott D. MD; Cockroft, Kevin M. MD, MSc
doi : 10.1161/STROKEAHA.122.041397
Based on the inclusion criteria of clinical trials, the degree of cervical carotid artery stenosis is often used as an indication for stent placement in the setting of extracranial carotid atherosclerotic disease.
van der Ende, Nadinda A.M. MD; Luijten, Sven P.R. MD; Kluijtmans, Leo MD; Postma, Alida A. MD, PhD; Cornelissen, Sandra A. MD, PhD; van Hattem, Antonius M.G. MD; Lycklama a Nijeholt, Geert J. MD, PhD; Bokkers, Reinoud P.H. MD, PhD; Thomassen, Lars MD, PhD; Waje-Andreassen, Ulrike MD, PhD; Logallo, Nicola MD, PhD; Bracard, Serge MD, PhD; Gory, Benjamin MD, PhD; Roozenbeek, Bob MD, PhD; Dippel, Diederik W.J. MD, PhD; van der Lugt, Aad MD, PhD
doi : 10.1161/STROKEAHA.122.042145
The Heidelberg Bleeding Classification, developed for computed tomography, is also frequently used to classify intracranial hemorrhage (ICH) on magnetic resonance imaging.
Adhicary, Subhodip PhD; Fanelli, Kayleigh MA; Nakisli, Sera BS; Ward, Brittney BS; Pearce, Isaac DO; Nielsen, Corinne M. PhD
doi : 10.1161/STROKEAHA.122.041853
Brain arteriovenous malformations (bAVM) are characterized by enlarged blood vessels, which direct blood through arteriovenous shunts, bypassing the artery-capillary-vein network and disrupting blood flow. Clinically, bAVM treatments are invasive and not routinely applicable.
Shimamura, Munehisa MD, PhD; Hayashi, Hiroki PhD; Ju, Nan MD, PhD; Yoshida, Shota MD, PhD; Baba, Satoshi MD; Sasaki, Tsutomu MD, PhD; Mochizuki, Hideki MD, PhD; Morishita, Ryuichi MD, PhD; Nakagami, Hironori MD, PhD
doi : 10.1161/STROKEAHA.122.041970
Although stimulation of Wnt/[beta]-catenin signaling is an important strategy to treat ischemic stroke, its signaling pathway has not been fully clarified yet
Nakano, Fumi MD, PhD; Kanamaru, Hideki MD, PhD; Kawakita, Fumihiro MD, PhD; Liu, Lei MD, PhD; Nakatsuka, Yoshinari MD, PhD; Nishikawa, Hirofumi MD, PhD; Okada, Takeshi MD, PhD; Suzuki, Hidenori MD, PhD
doi : 10.1161/STROKEAHA.122.041977
Early brain injury including neuronal apoptosis is a main contributor to neurological deterioration after subarachnoid hemorrhage (SAH).
Sasaki, Natsuhi MD; Ishii, Akira MD, PhD; Yagi, Shinichi PhD; Nishi, Hidehisa MD, PhD; Akiyama, Ryo MD; Okawa, Masakazu MD, PhD; Abekura, Yu MD, PhD; Tsuji, Hirofumi MD; Sakurai, Shinichi PhD; Miyamoto, Susumu MD, PhD
doi : 10.1161/STROKEAHA.122.042043
Permanent metallic flow diverter (FD) implantation for treatment of intracranial aneurysms requires antiplatelet therapy for an unclear duration and restricts postprocedural endovascular access
Mai, Hongcheng MD ,,,,*; Zhang, Tianyuan MD ,,*; Zhang, Tao MD, PhD ,*; Lu, Aijun MD; Wu, Zhengdong MD; Yang, Bing MD; He, Niu MSc; Liu, Xiaoyan MD, PhD; Tsang, Chi Kwan PhD; Xu, Anding MD, PhD; Lu, Dan MD, PhD
doi : 10.1161/STROKEAHA.123.042486
The soft regions of a thrombus tend to be more susceptible to r-tPA (recombinant tissue-type plasminogen activator)-mediated thrombolysis and are more easily removed by mechanical thrombectomy than the stiff counterpart.
Demura, Munehiro MD; Ishii, Hiroshi MD, PhD; Takarada-Iemata, Mika PhD; Kamide, Tomoya MD, PhD; Yoshikawa, Akifumi MD, PhD; Nakada, Mitsutoshi MD, PhD; Hori, Osamu MD, PhD
doi : 10.1161/STROKEAHA.123.042799
Although early brain injury (EBI) is recognized as a critical step following subarachnoid hemorrhage (SAH), its pathophysiology and underlying mechanisms remain poorly understood.
Caldeira, Daniel MD, PhD; Alves da Silva, Pedro MD; Pinto, Fausto J. MD, PhD
doi : 10.1161/STROKEAHA.122.041628
Falls are always a concern regarding the balance of risk/benefit in patients with atrial fibrillation treated with anticoagulants. In this analysis, we aimed to evaluate the outcomes of patients that had a fall/head injury reported in the RE-LY clinical trial (Randomized Evaluation of Long-Term Anticoagulation Therapy) and to explore the safety of dabigatran (a nonvitamin K antagonist oral anticoagulant).
Sarfo, Fred Stephen MD, PhD; Akinyemi, Joshua Odunayo PhD; Obiako, Reginald PhD; Nichols, Michelle PhD; Fakunle, Adekunle Gregory PhD; Adusei, Nathaniel BA; Ampofo, Michael BA; Arulogun, Oyedunni PhD; Jenkins, Carolyn PhD; Akpa, Onoja M. PhD; Aribisala, Benjamin PhD; Abdulrasaq, Saheed BSc; Akinyemi, Rufus MD, PhD; Ovbiagele, Bruce MD; Owolabi, Mayowa O. MD, DrM
doi : 10.1161/STROKEAHA.123.042618
Using tailored mobile health interventions to improve global vascular risk awareness and control is yet to be investigated for primary stroke prevention in Africa.
Orbach, Darren B. MD, PhD; Wilkins-Haug, Louise E. MD, PhD; Benson, Carol B. MD; Tworetzky, Wayne MB, ChB; Rangwala, Shivani D. MD; Guseh, Stephanie H. MD; Gately, Nicole K. RN; Stout, Jeffrey N. PhD; Mizrahi-Arnaud, Arielle MD; See, Alfred P. MD
Singh, Nishita MD; Cimflova, Petra MD; Ospel, Johanna Maria MD; Kashani, Nima MD; Marko, Martha MD; Mayank, Arnuv MD; Hill, Michael D. MD; on behalf of the ESCAPE-NA1 Trial Investigators
Zedde, Marialuisa MD; Napoli, Manuela MD, PhD; Moratti, Claudio MD; Pascarella, Rosario MD
Marzoughi, Sina MD; Hennawy, Mirna MD; Al Hashash, Hessah MD; Zhou, Lily W. MD
Bravata, Dawn M. MD; Purvis, Tara MSci; Ding, Qinglan Pricilla PhD; Waddell, Kimberly J. PhD; Kilkenny, Monique F. PhD
Perla, Maharajni BSA; Caretti, Viola MD, PhD; Moro, Maria A. PhD; McCullough, Louise D. MD, PhD
Desai, Shashvat M. MD; Psychogios, Marios MD; Khatri, Pooja MD; Jovin, Tudor G. MD; Jadhav, Ashutosh P. MD, PhD
doi : 10.1161/STROKEAHA.122.033447
AB The therapeutic focus in acute ischemic stroke over the last 2.5 decades has been to balance the benefits of rapid reperfusion therapy with the risks of treatment-related complications. Both intravenous thrombolytics and endovascular thrombectomy are proven to substantially improve outcomes in a time-dependent manner.
Das, Saurav MD; Goldstein, Eric D. MD; de Havenon, Adam MD; Abbasi, Mehdi MD; Nguyen, Thanh N. MD; Aguiar de Sousa, Diana MD; Yaghi, Shadi MD
doi : 10.1161/STROKEAHA.122.038563
AB Occlusive and nonocclusive cervicocephalic thrombi can be encountered during neurovascular imaging in patients with acute ischemic stroke. Radiographic and morphological characteristics on basic and advanced imaging modalities can be important clues towards determination of pathomechanism and the choice of acute and subacute treatment modalities.
de Havenon, Adam MD, MS; Zaidat, Osama O. MD; Amin-Hanjani, Sepideh MD; Nguyen, Thanh N. MD; Bangad, Aaron BA; Abbasi, Mehdi MD; Anadani, Mohammad MD; Almallouhi, Eyad MD; Chatterjee, Rano MD; Mazighi, Mikael MD, PhD; Mistry, Eva A. MBBS, MSCI; Yaghi, Shadi MD; Derdeyn, Colin P. MD; Hong, Keun-Sik MD; Kvernland, Alexandra MD; Leslie-Mazwi, Thabele M. MD; Al Kasab, Sami MD
doi : 10.1161/STROKEAHA.122.040008
AB Large vessel occlusion stroke due to underlying intracranial atherosclerotic disease (ICAD-LVO) is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk factors, race and ethnicity, and age.
Hazelton, Christine PhD; Thomson, Katie PhD; Todhunter-Brown, Alex PhD; Campbell, Pauline PhD; Chung, Charlie S.Y. PhD; Dorris, Liam DClinPsy; Gillespie, David C. PhD; Hunter, Susan M. PhD; McGill, Kris PhD; Nicolson, Donald J. PhD; Williams, Linda J. PhD; Brady, Marian C. PhD
Hurst, David A. BS; Sohrabji, Farida PhD
McAree, Michael DO; Sharashidze, Vera MD
Lyman, Kyle A. MD, PhD; Sreekrishnan, Anirudh MD, MHS; Thatikunta, Prateek MD; McConnell, Ryan MD; Lansberg, Maarten G. MD, PhD; Mijalski Sells, Christina M. MD, MPH
Iadecola, Costantino MD, Chair; Smith, Eric E. MD, FAHA, Vice Chair; Anrather, Josef VMD; Gu, Chenghua PhD; Mishra, Anusha PhD; Misra, Sanjay MD, FAHA; Perez-Pinzon, Miguel A. PhD, FAHA; Shih, Andy Y. PhD; Sorond, Farzaneh A. MD; van Veluw, Susanne J. PhD; Wellington, Cheryl L. PhD; on behalf of the American Heart Association Stroke Council Council on Arteriosclerosis Thrombosis and Vascular Biology Council on Cardiovascular Radiology and Intervention Council on Hypertension Council on Lifestyle and Cardiometabolic Health
doi : 10.1161/STR.0000000000000431
Preservation of brain health has emerged as a leading public health priority for the aging world population. Advances in neurovascular biology have revealed an intricate relationship among brain cells, meninges, and the hematic and lymphatic vasculature (the neurovasculome) that is highly relevant to the maintenance of cognitive function.
El Husseini, Nada MD, MHSc, FAHA, Chair; Katzan, Irene L. MD, MS, FAHA, Vice Chair; Rost, Natalia S. MD, MPH, FAHA; Blake, Margaret Lehman PhD, CCC-SLP; Byun, Eeeseung RN, PhD; Pendlebury, Sarah T. FRCP, DPhil; Aparicio, Hugo J. MD, MPH; Marquine, Maria J. PhD; Gottesman, Rebecca F. MD, PhD, FAHA; Smith, Eric E. MD, MPH, FAHA; on behalf of the American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; and Council on Lifestyle and Cardiometabolic Health
doi : 10.1161/STR.0000000000000430
Cognitive impairment is a common consequence of stroke and has direct implications for poststroke functioning and quality of life, including the ability to maintain a job, live independently, sustain interpersonal relationships, and drive a vehicle.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟